5.1: Information to be provided to prospective donors of blood or blood components The following information must be provided to all donors: Accurate educational material…
4.8: Protection and preservation of donation quality All blood and components must be transported, tested and stored in accordance with the specificat…
4.6: Records It is strongly recommended that all records pertaining to donor and donation identity be entered and maintained in an electronic format which can be accessed re…
4.5: Labelling Session staff must ensure that a set of labels with a unique number is assigned to each donation and that the same unique number appears on the donor se…
22.9: Labelling, packaging, transportation and release The mandatory requirements for these are described in the HTA’s Guide to Quality and Safety Assurance for Human Tissue and Cells fo…
22.8: Requirements for the timing of testing Please see Annex 7 for guidance relating to the timing of testing for different categories of HPC.
22.7: Testing of haemopoietic progenitor cell donors and components Infectious disease marker testing, ABO and RhD typing and clonogenic assays must be done in accordance with the HTA gu…
Type the first few letters of what you are looking for until it appears below. The topic you are taken to will contain the relevant information you are looking for.
Change Notification No. 29-2023 - Chronic Fatigue Syndrome.pdf (168KB)
Change Notification No. 28-2023 - Blood Safety Entry.pdf (155KB)
Change Notification No. 27-2023 - Air Crew and Air Traffic Controllers.pdf (213KB)